Imidazo[1,2-b][1,2,4]triazines as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety

Bioorg Med Chem Lett. 2006 Mar 15;16(6):1477-80. doi: 10.1016/j.bmcl.2005.12.044. Epub 2006 Jan 4.

Abstract

Imidazo[1,2-a]pyrimidines and imidazo[1,2-b][1,2,4]triazines are ligands for the benzodiazepine binding site of GABA(A) receptors that are functionally selective for the alpha2/alpha3 subtypes over the alpha1 subtype. SAR studies to optimise this functional selectivity, pharmacokinetic and behavioural data are described.

MeSH terms

  • Administration, Oral
  • Animals
  • Anxiety Disorders / drug therapy*
  • Ataxia / drug therapy
  • Binding Sites
  • Biological Availability
  • Disease Models, Animal
  • Dogs
  • Female
  • GABA Agonists / pharmacokinetics
  • GABA Agonists / pharmacology
  • GABA-A Receptor Agonists*
  • Imidazoles / pharmacokinetics
  • Imidazoles / pharmacology*
  • Male
  • Maze Learning / drug effects
  • Molecular Structure
  • Protein Subunits / agonists*
  • Protein Subunits / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, GABA-A / metabolism
  • Saimiri
  • Structure-Activity Relationship
  • Triazines / pharmacokinetics
  • Triazines / pharmacology*

Substances

  • GABA Agonists
  • GABA-A Receptor Agonists
  • Gabra2 protein, mouse
  • Gabra3 protein, mouse
  • Imidazoles
  • Protein Subunits
  • Receptors, GABA-A
  • Triazines